Observational studyMedicina (Kaunas, Lithuania)2025

Effects of Empagliflozin on Sarcopenia Risk, Body Composition, and Muscle Strength in Type 2 Diabetes: A 24-Week Real-World Observational Study.

Deniz Çetin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.